ARCHIVES

R01 Payline To Increase From 21st to 22nd Percentile; Barcelona Hospital Wins BMS Cancer Research Grant

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010

In Congress: Senate Passes Bill For DOD Medical Research Funding

August 14, 1998